TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 26 filers reported holding TSCAN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $664,184 | +144.9% | 259,447 | +139.2% | 0.00% | – |
| Q2 2023 | $271,188 | -1.7% | 108,475 | -17.4% | 0.00% | – |
| Q1 2023 | $275,770 | +321.9% | 131,319 | +211.4% | 0.00% | – |
| Q4 2022 | $65,371 | -66.8% | 42,175 | -34.7% | 0.00% | – |
| Q3 2022 | $197,000 | +9.4% | 64,570 | +13.1% | 0.00% | – |
| Q2 2022 | $180,000 | +63.6% | 57,089 | +46.1% | 0.00% | – |
| Q1 2022 | $110,000 | -10.6% | 39,076 | +42.6% | 0.00% | – |
| Q4 2021 | $123,000 | -47.7% | 27,404 | -2.9% | 0.00% | – |
| Q3 2021 | $235,000 | – | 28,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $976,500 | 26.44% |
| Deer Management Co. LLC | 1,245,505 | $1,930,533 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 514,655 | $797,715 | 0.12% |
| Alphabet Inc. | 1,077,080 | $1,647,932 | 0.10% |
| Newtyn Management, LLC | 230,000 | $374,900 | 0.08% |
| DC Investments Management, LLC | 35,563 | $55,123 | 0.07% |
| Baker Brothers Advisors | 2,784,792 | $4,316,428 | 0.03% |
| Privium Fund Management (UK) Ltd | 15,825 | $24,529 | 0.02% |
| Tekla Capital Management LLC | 200,000 | $326,000 | 0.01% |
| NewEdge Wealth, LLC | 91,463 | $141,768 | 0.01% |